Search Results - "Thakuria, Mayuri"

Clinical Performance of the Optiflux® F160NR Dialyzer: PUB089 by Meyer, Jill M., Steer, Dylan, Weber, Lisa A., Thakuria, Mayuri, Ho, Chiang-Hong, Mullon, Claudy, Kossmann, Robert J.

Get full text

Clinical Safety of a New Hemodialyzer with the Surface Modifying Molecule EndexoTM: PO1132 by Meyer, Jill M., Steer, Dylan, Weber, Lisa A., Thakuria, Mayuri, Ho, Chiang-Hong, Mullon, Claudy, Kossmann, Robert J.

Get full text

Safety of a Novel Dialyzer Containing a Fluorinated Polyurethane Surface-Modifying Macromolecule in Patients with End-Stage Kidney Disease by Meyer, Jill M, Steer, Dylan, Weber, Lisa A, Zeitone, Abeer A, Thakuria, Mayuri, Ho, Chiang-Hong, Aslam, Shakil, Mullon, Claudy, Kossmann, Robert J

“…By inhibiting the adsorption of protein and platelets, surface-modifying macromolecules (SMMs) may improve the hemocompatibility of hemodialyzers. This trial…”
Get more information

Effects of Crit-Line® monitor use on patient outcomes and epoetin alfa dosing following onset of hemodialysis: a propensity score-matched study by Sibbel, Scott P, Ficociello, Linda H, Black, Michael, Thakuria, Mayuri, Mullon, Claudy, Diaz-Buxo, Jose, Alfieri, Thomas J

“…The Crit-Line® monitor (CLM) is a device for monitoring hematocrit, oxygen saturation and change in intravascular blood volume during hemodialysis. Prior…”
Get more information

Anemia Management in Patients Receiving Chronic Hemodialysis by Thakuria, Mayuri, Ofsthun, Norma J., Mullon, Claudy, Diaz-Buxo, Jose A.

“…Anemia treatment in hemodialysis‐dependent (HDD) CKD patients involves adequate supply of iron and an erythropoiesis‐stimulating agent (ESA). Despite…”
Get full text